🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

INSIGHT (Insight Into Nephrotic Syndrome)

Recruitingn/aAges 6 Months - 18 YearsAllThe Hospital for Sick Children
NCT01605266 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

INSIGHT is a longitudinal study of childhood nephrotic syndrome to determine genetic, serologic and environmental factors contributing to nephrotic syndrome and disease progression.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. diagnosis of nephrotic syndrome 2. signed informed consent and assent appropriate for age 3. ages 6 months -18 years old and 4. ability to complete questionnaires Exclusion Criteria: 1. congenital nephrotic syndrome (less than age 1) 2. syndromic disease with multiple organ involvement 3. inability to provide consent by primary care providers 4. conditions such as systemic lupus erythematous.
💊

What it tests

  • Not listed
📍

Where

4 sites
William Osler Health System, Brampton Civic Hospital and Peel Memorial Centre for Integrated Health and Wellness
Brampton, Canada
Hamilton Health Sciences Corporation - McMaster University Medical Centre
Hamilton, Canada
Rouge Valley Health System, Rouge Valley Centenary
Scarborough Village, Canada
The Hospital for Sick Children
Toronto, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy